首页> 美国卫生研究院文献>BMJ Case Reports >Novel treatment (new drug/intervention; established drug/procedure in new situation): Resolution of severe hepato-pulmonary syndrome following transjugular portosystemic shunt procedure
【2h】

Novel treatment (new drug/intervention; established drug/procedure in new situation): Resolution of severe hepato-pulmonary syndrome following transjugular portosystemic shunt procedure

机译:新疗法(新药/干预;新情况下已确立的药物/程序):经颈静脉门体分流手术后重症肝肺综合征的解决

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The hepato-pulmonary syndrome (HPS) is a relatively common complication of hepatic disease that leads to hypoxaemia and dyspnoea secondary to pulmonary shunting. A number of pharmacological therapies have been trialled, yet liver transplantation remains the only definitive treatment. The use of a transjugular intrahepatic portosystemic shunt (TIPS) to reduce portal hypertension and improve oxygenation remains controversial in HPS due to the lack of large clinical series or randomised controlled trials. We present a case of HPS successfully treated with TIPS and review the relevant literature.
机译:肝肺综合征(HPS)是一种相对常见的肝病并发症,可导致继发于肺分流的低氧血症和呼吸困难。已经尝试了多种药物疗法,但是肝移植仍然是唯一的确定性疗法。由于缺乏大型临床试验或随机对照试验,在颈动脉高压中使用经颈静脉肝内门体分流术(TIPS)来降低门脉高压和改善氧合作用仍存在争议。我们介绍了一个成功用TIPS治疗过的HPS病例,并复习了相关文献。

著录项

相似文献

  • 外文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号